Data from Oncomine and TIMER2 both demonstrated that compared with normal tissues, PLOD2 mRNA level was significantly upregulated in tumor tissues in HNSCC patients (Figure 2a,b). Here, PLOD2 is linked to head and neck squamous cell carcinoma.